Mkt Cap$2.27T-1.15%
24h Vol$65.20B
BTC Dom56.5%
ETH Dom9.9%
F&G28Fear
BTC$63,842.00-1.34% ETH$1,853.15-1.82% USDT$0.9991-0.01% BNB$559.58-1.14% USDC$0.99990.00% XRP$1.09-1.99% SOL$73.73-3.02% TRX$0.3302+1.20% FIGR_HELOC$1.04+3.79% HYPE$58.71+0.10% DOGE$0.0686-1.50% RAIN$0.0142+0.90% USDS$0.9999+0.01% LEO$9.64-0.88% ZEC$490.88-4.53% XMR$358.43+1.99% BTC$63,842.00-1.34% ETH$1,853.15-1.82% USDT$0.9991-0.01% BNB$559.58-1.14% USDC$0.99990.00% XRP$1.09-1.99% SOL$73.73-3.02% TRX$0.3302+1.20% FIGR_HELOC$1.04+3.79% HYPE$58.71+0.10% DOGE$0.0686-1.50% RAIN$0.0142+0.90% USDS$0.9999+0.01% LEO$9.64-0.88% ZEC$490.88-4.53% XMR$358.43+1.99%
News

AVXL

Total Stories
2
Section
AVXL
Why Anavex (AVXL) Is Down 50% Today: EMA Rejects Alzheimer's Drug Progress
Market Analysis

Why Anavex (AVXL) Is Down 50% Today: EMA Rejects Alzheimer’s Drug Progress

Anavex stock plunged 50% in premarket trading after European regulators issued a negative vote on its Alzheimer’s drug blarcamesine.

Tim FriesNov 14, 20253 min read